+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biological Safety Cabinet Market by Class, Type, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 181 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011395
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biological Safety Cabinet Market grew from USD 494.74 million in 2024 to USD 538.87 million in 2025. It is expected to continue growing at a CAGR of 8.51%, reaching USD 807.65 million by 2030.

Unveiling the Critical Role of Biosafety Cabinets in Modern Laboratories

Biosafety cabinets serve as the frontline defense in laboratories worldwide, safeguarding researchers, specimens, and the environment from hazardous biological agents. As vital components in academic centers, clinical facilities, industrial research labs, and pharmaceutical environments, these cabinets uphold rigorous containment standards that enable progress in life sciences and public health.

Recent global challenges have underscored the importance of robust biosafety infrastructure. Laboratories have accelerated the integration of advanced containment solutions to mitigate emerging threats and comply with evolving regulations. Against this backdrop, understanding the technological evolution, regulatory shifts, and market dynamics surrounding biosafety cabinets has never been more critical. This study delivers a comprehensive exploration of the factors reshaping the landscape, offering decision-makers clarity on risk mitigation, investment priorities, and strategic planning.

Emerging Technological and Regulatory Paradigm Shifts in Biosafety Cabinets

The biosafety cabinet sector stands at the cusp of a new era driven by innovation and heightened regulatory scrutiny. Technological advancements such as real-time monitoring systems and predictive maintenance algorithms are transforming how containment equipment operates and is serviced. These enhancements streamline workflow efficiency and elevate safety standards by providing continuous assurance of performance integrity.

In parallel, regulations governing biosafety protocols are undergoing significant revisions to address novel pathogens and evolving research methodologies. This regulatory tightening compels manufacturers and end users to adopt next-generation cabinet designs that integrate more sophisticated filtration, more robust alarm systems, and enhanced ergonomic features. Organizations that anticipate these shifts and invest in adaptable solutions will not only meet compliance requirements but also gain a competitive advantage in a rapidly maturing market.

Assessing the Ripple Effects of US Tariff Policies on Biosafety Equipment

The implementation of new tariff measures in the United States has exerted a profound influence on the biosafety cabinet supply chain. Increased duties on imported components have elevated production expenses, prompting manufacturers to explore alternative sourcing strategies. Many have accelerated partnerships with domestic suppliers and regional fabrication facilities to maintain cost stability and ensure uninterrupted delivery schedules.

Simultaneously, end users are reassessing procurement practices to mitigate exposure to price volatility. Some institutions are consolidating orders or extending service agreements to achieve economies of scale and predictable budgeting. Others are evaluating total cost of ownership more rigorously, factoring in maintenance, energy consumption, and potential downtime. As a result, the market is experiencing a recalibration of vendor relationships and procurement frameworks, with long-term contracts and collaborative agreements emerging as preferred models to navigate tariff-induced challenges.

Deep Dive into Market Segmentation by Class, Configuration, End User, and Application

Analyzing the market through the lens of class reveals distinct dynamics across containment levels. Class I cabinets provide fundamental protection, while Class III enclosures deliver the highest degree of isolation for work with severe hazards. The diverse subclasses within Class II-A1, A2, B1, and B2-accommodate varied airflow requirements and spill containment capabilities, influencing purchasing decisions based on laboratory processes and safety protocols. Vertical and horizontal configurations offer optimized workflow orientations, with the former favored for general microbiology workflows and the latter for applications demanding extensive benchtop access.

End users shape demand in unique ways. Academic and research institutes prioritize flexibility for multiple projects, hospitals and clinical laboratories emphasize compliance and patient safety, industrial research facilities demand robust throughput capabilities, and pharmaceutical and biotech companies seek GMP-compliant solutions. Application areas further differentiate requirements: cell culture applications demand tight contamination control, diagnostic workflows require rapid sample throughput, microbiology investigations depend on precise environmental parameters, and pharmaceutical testing mandates strict adherence to validation protocols. These intersecting segmentation dimensions guide manufacturers in tailoring design features and service offerings to meet specialized laboratory needs.

Regional Dynamics Shaping Biosafety Cabinet Demand Worldwide

The Americas exhibit a strong orientation toward research-intensive laboratories bolstered by substantial government funding and established life sciences clusters. Institutional investments in containment infrastructure remain high, driven by both public health initiatives and pharmaceutical R&D expansion. In Europe, Middle East & Africa, regulatory harmonization across diverse jurisdictions fosters a demand for cabinets that meet stringent unified standards, while regional public health priorities catalyze investments in clinical and diagnostic settings. Asia-Pacific is witnessing rapid growth fueled by rising biomanufacturing capacity, expanding academic research networks, and increased focus on domestic pharmaceutical development. Local manufacturing capabilities are scaling swiftly to meet regional demand, and emerging economies are prioritizing biosafety upgrades in response to public health modernization programs.

Competitive Landscape and Leading Biosafety Cabinet Manufacturers

Market leadership is concentrated among established global manufacturers that have built reputations on reliability, certification compliance, and comprehensive service networks. These companies continue to invest heavily in R&D, driving innovations in energy efficiency, digital integration, and user-centered design. Strategic partnerships with component suppliers and accreditation agencies reinforce their ability to deliver certified solutions across multiple markets.

Emerging niche players are carving out specialized positions by focusing on turnkey installation packages, rapid-response maintenance services, and modular product offerings. Their agility in responding to localized requirements and providing tailored support has resonated with academic and industrial clients seeking personalized solutions. Collaboration between these agile entrants and legacy producers is also becoming more prominent, as co-development initiatives aim to combine cutting-edge technologies with established manufacturing expertise.

Strategic Imperatives for Industry Leaders to Advance Biosafety Solutions

Industry leaders should prioritize the integration of digital sensor networks and remote monitoring platforms to enable predictive maintenance and minimize unexpected downtime. Investing in modular cabinet architectures will enhance adaptability to evolving laboratory workflows and streamline upgrades for new containment requirements. Strengthening supply chain resilience through strategic sourcing partnerships and multi-region manufacturing footprints will mitigate the impact of external policy shifts and material shortages.

Aligning product development with forthcoming regulatory updates and harmonized international standards will position organizations as preferred partners for compliance-driven end users. Expanding service offerings to include comprehensive validation support, operator training programs, and lifecycle management solutions will foster long-term customer relationships and recurring revenue streams. Finally, pursuing collaborations with academic research centers and technology incubators can accelerate innovation cycles and uncover emerging application opportunities.

Robust Research Framework Underpinning Our Biosafety Cabinet Study

This study is founded on a rigorous research framework combining in-depth primary interviews with laboratory managers, procurement executives, and regulatory experts. Secondary research encompassed peer-reviewed publications, industry standards documentation, and regulatory filings to contextualize technological and policy developments. Data triangulation methods ensured the reliability and consistency of insights, while scenario analysis provided clarity on potential market trajectories.

Segment-specific and region-specific information was systematically validated through multiple data points, including installation records, maintenance logs, and capital expenditure reports. A continuous peer review process by technical specialists and market strategists guaranteed methodological robustness and minimized bias. Comprehensive quality assurance protocols were applied at each stage, from data collection through interpretation, to deliver a transparent and defensible research outcome.

Concluding Insights on the Future Trajectory of Biosafety Cabinet Market

As the biosafety cabinet market continues its evolution, stakeholders must navigate a landscape shaped by accelerating technological innovation, regulatory complexity, and shifting economic policies. The convergence of real-time monitoring, sustainable operations, and user-centric design will define the next generation of containment solutions. Organizations that proactively incorporate these elements into their strategic planning will secure competitive differentiation and long-term growth.

Collaboration across the value chain-from component suppliers to end users and regulatory bodies-will be essential to harmonize standards and drive innovation. By embracing data-driven decision-making and investing in adaptive infrastructure, laboratories and manufacturers can safeguard research integrity, protect human health, and support breakthroughs across life sciences disciplines.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Class
    • Class I
    • Class II
      • A1
      • A2
      • B1
      • B2
    • Class III
  • Type
    • Horizontal
    • Vertical
  • End User
    • Academic & Research Institutes
    • Hospitals & Clinical Laboratories
    • Industrial R & D
    • Pharmaceutical & Biotech
  • Application
    • Cell Culture
    • Diagnostics
    • Microbiology
    • Pharmaceutical Testing
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Thermo Fisher Scientific Inc.
  • Esco Micro Pte. Ltd.
  • Labconco Corporation
  • NuAire, Inc.
  • The Baker Company, Inc.
  • Getinge AB
  • Telstar, S.L.
  • Germfree Laboratories, Inc.
  • Air Science International, LLC
  • AirClean Systems, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biological Safety Cabinet Market, by Class
8.1. Introduction
8.2. Class I
8.3. Class II
8.3.1. A1
8.3.2. A2
8.3.3. B1
8.3.4. B2
8.4. Class III
9. Biological Safety Cabinet Market, by Type
9.1. Introduction
9.2. Horizontal
9.3. Vertical
10. Biological Safety Cabinet Market, by End User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Hospitals & Clinical Laboratories
10.4. Industrial R & D
10.5. Pharmaceutical & Biotech
11. Biological Safety Cabinet Market, by Application
11.1. Introduction
11.2. Cell Culture
11.3. Diagnostics
11.4. Microbiology
11.5. Pharmaceutical Testing
12. Americas Biological Safety Cabinet Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Biological Safety Cabinet Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Biological Safety Cabinet Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Esco Micro Pte. Ltd.
15.3.3. Labconco Corporation
15.3.4. NuAire, Inc.
15.3.5. The Baker Company, Inc.
15.3.6. Getinge AB
15.3.7. Telstar, S.L.
15.3.8. Germfree Laboratories, Inc.
15.3.9. Air Science International, LLC
15.3.10. AirClean Systems, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIOLOGICAL SAFETY CABINET MARKET MULTI-CURRENCY
FIGURE 2. BIOLOGICAL SAFETY CABINET MARKET MULTI-LANGUAGE
FIGURE 3. BIOLOGICAL SAFETY CABINET MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. BIOLOGICAL SAFETY CABINET MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. BIOLOGICAL SAFETY CABINET MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOLOGICAL SAFETY CABINET MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS I, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY A1, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY A2, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY B1, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY B2, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS III, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY HORIZONTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY VERTICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY INDUSTRIAL R & D, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL & BIOTECH, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY PHARMACEUTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 41. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 42. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. CANADA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 46. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 47. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 68. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. UNITED KINGDOM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 72. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 73. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. GERMANY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 77. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 78. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. FRANCE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. RUSSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 87. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 88. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. ITALY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 92. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 93. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. SPAIN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. UNITED ARAB EMIRATES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 103. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. SAUDI ARABIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 108. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. SOUTH AFRICA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 112. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 113. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. DENMARK BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 118. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. NETHERLANDS BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 122. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 123. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 125. QATAR BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 127. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 128. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. FINLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 142. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 143. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. EGYPT BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 147. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 148. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 149. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. TURKEY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 157. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 158. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 159. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. NORWAY BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 162. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 163. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 164. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. POLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 168. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 169. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SWITZERLAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. ASIA-PACIFIC BIOLOGICAL SAFETY CABINET MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 177. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 178. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 179. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 181. CHINA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 183. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 184. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 185. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. INDIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 188. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 189. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. JAPAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. AUSTRALIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. SOUTH KOREA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 205. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. INDONESIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 208. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 209. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. THAILAND BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. PHILIPPINES BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 224. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 225. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. SINGAPORE BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. VIETNAM BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY CLASS II, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. TAIWAN BIOLOGICAL SAFETY CABINET MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. BIOLOGICAL SAFETY CABINET MARKET SHARE, BY KEY PLAYER, 2024
TABLE 238. BIOLOGICAL SAFETY CABINET MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Biological Safety Cabinet market report include:
  • Thermo Fisher Scientific Inc.
  • Esco Micro Pte. Ltd.
  • Labconco Corporation
  • NuAire, Inc.
  • The Baker Company, Inc.
  • Getinge AB
  • Telstar, S.L.
  • Germfree Laboratories, Inc.
  • Air Science International, LLC
  • AirClean Systems, Inc.

Methodology

Loading
LOADING...

Table Information